Annual General Meeting 2025

Last update 11 March 2025

Below you will find the countermotions and election nominations from shareholders for our Annual General Meeting to be held on Friday, 26 March 2025, which have been submitted to us within the period stipulated in Sections 126 (1) and 127 AktG.

It is to be noted that motions and election nominations will only be considered at the Annual General Meeting if they are submitted orally, even if they have been submitted to the Company in advance in due time.

Countermotions and election nominations are marked separately on the reply form and in the shareholder portal. In the event of a vote, you agree with the countermotions or election nominations by voting using the separately marked countermotions or election nominations or by issuing a corresponding instruction. Countermotions that merely reject the management's proposals are not marked separately. If you wish to approve these countermotions, you must vote “no” to the corresponding item on the agenda.

The separately marked countermotions or election nominations will probably only be voted on if the resolution proposal of the management on the respective agenda item is defeated.

The proposals and justifications reflect the views of the authors as communicated to us. Factual claims have also been published unchanged and without verification by us. The Company accepts no responsibility for this content, nor does the Company adopt it as its own.

In connection with election nominations from shareholders, we would point out that the Supervisory Board of Carl Zeiss Meditec AG must be composed of at least 30% women and at least 30% men in accordance with Section 96 (2) sentence 1 of the German Stock Corporation Act. The shareholder representatives on the Supervisory Board have objected to the principle of overall fulfillment, requesting that the minimum proportion of 30% for women and 30% for men must be fulfilled separately by the shareholder representatives and the employee representatives. In order to fulfill this quota, at least two seats on the Supervisory Board must be occupied by female members and two seats by male members each on both the shareholder and the employee side.